Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Aug 11;9(8):2600. doi: 10.3390/jcm9082600

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Flow chart of study. Left panel show study procedures. ^# Sodium-glucose cotransporter-2 (SGLT-2) inhibitors: Patients who had initiated SGLT-2 inhibitors at discharge from the cardiology department. ^δ Non-SGLT-2 inhibitors: Patients with glucose-lowering drugs (GLD) but without SGLT-2 inhibitors at discharge from the cardiology department. * New diagnosis of type 2 diabetes mellitus (T2DM) during hospitalization according to the American Diabetes Association criteria (19). ^Φ Glycemic profile: Glycated hemoglobin and fasting plasma glucose. DM: diabetes mellitus; FPG: fasting plasma glucose; GLD: glucose-lowering drugs; SGLT-2: sodium-glucose cotransporter-2; T1DM: type 1 diabetes mellitus; T2DM: type 2 diabetes mellitus.